This general information is not intended to diagnose any medical condition or to replace your healthcare professional
STEP 1 semaglutide obesity trial Trial Primary trial source for semaglutide 2.4 mg weight-loss expectations and side effects
Since medication remains in your system for about five weeks after your last dose, side effects like nausea typically improve over 2 to 3 weeks as semaglutide levels decline
Oakley AJ, Yamada T, Liu D, Coggan M, Clark AG, Board PG
Membranes were subsequently stripped and incubated with anti-SNAP tag rabbit polyclonal antibody (P9310S, New England Biolabs, 1:1,000) followed by goat anti-rabbit HRP secondary antibody (ab6721, Abcam, 1:2,000) to detect total level of immunoprecipitated SNAP/FLAG-hGLP-1R per sample